Gene test could find right blood thinner to stop second strokes
NCT ID NCT06714526
Summary
This study is testing whether using a genetic test to choose between two blood-thinning medications (clopidogrel or ticagrelor) works better than the standard approach for preventing another stroke. It involves 100 adults who recently had a stroke or mini-stroke caused by narrowed arteries inside the brain. Researchers will compare if the genetic testing approach is practical and safe, and if it leads to fewer new strokes and better recovery over 90 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dr. Mark I. Boulos - Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N3M5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Calgary
NOT_YET_RECRUITINGCalgary, Alberta, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.